Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)

v3.20.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accum. Other Comprehensive Income (Loss)
Non-Controlling Interests
Total
Balance at Beginning at Dec. 31, 2018 $ 1 $ 46 $ 932,179 $ (630,000) $ (2,459) $ 19,598 $ 319,365
Balance at Beginning (in shares) at Dec. 31, 2018 927 45,771          
Stock-based compensation expense - restricted stock issued to employees and directors, net of cancellations and tax 797 797
Stock-based compensation expense - restricted stock issued to employees and directors, net of cancellations and tax (in shares) (24)          
Issuances of common stock $ 3 3,667 3,670
Issuances of common stock (in shares) 3,137          
Preferred stock dividends (312) (312)
Net loss (12,890) (1,271) (14,161)
Balance at End at Mar. 31, 2019 $ 1 $ 49 936,643 (643,202) (2,459) 18,327 309,359
Balance at End (in shares) at Mar. 31, 2019 927 48,884          
Balance at Beginning at Dec. 31, 2019 $ 1 $ 56 942,307 (720,214) (2,370) 7,265 227,045 [1]
Balance at Beginning (in shares) at Dec. 31, 2019 927 55,508          
Stock-based compensation expense - restricted stock issued to employees and directors, net of cancellations and tax $ (4) 868 864
Stock-based compensation expense - restricted stock issued to employees and directors, net of cancellations and tax (in shares) (38)          
Issuances of common stock $ 4 278 282
Issuances of common stock (in shares) 421          
Preferred stock dividends (315) (315)
Net loss (25,100) (2,056) (27,156)
Balance at End at Mar. 31, 2020 $ 1 $ 56 $ 943,453 $ (745,629) $ (2,370) $ 5,209 $ 200,720
Balance at End (in shares) at Mar. 31, 2020 927 55,891          
[1] Amounts derived from the audited financial statements for the year ended December 31, 2019.